welcome
About us
Newsletter
News Widget
Media Inquiries

Summary

FDA Endorses Gilead's HIV Drug

This is a America news story, published by CNBC, that relates primarily to Trump news.

America news

For more America news, you can click here:

more America news

Trump news

For more Trump news, you can click here:

more Trump news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

CNBC news

For more news from CNBC, you can click here:

more news from CNBC

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

HIV prevention medications

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest yearly antiviral drug news, HIV treatment news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

yearly antiviral injection
CNBC

CNBC

•

Health

Health

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

CNBC
Summary
Nutrition label

84% Informative

The Food and Drug Administration approves Gilead 's twice-yearly antiviral drug for preventing HIV.

The launch of the injectable drug, lenacapavir, faces a set of potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts.

Patients take it less frequently than all existing HIV prevention medications, including daily pills.

PrEP4All's Johnson says the "entire foundation for HIV prevention in America is under attack" The White House's proposed budget for fiscal year 2026 includes deep cuts to several HIV prevention programs.

Medicaid is the largest source of insurance coverage for people who have HIV in the U.S. , covering 40% of nonelderly adults with HIV.

VR Score

86

Informative language

86

Neutral language

48

Article tone

formal

Language

English

Language complexity

59

Offensive language

likely offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

10

https://www.gilead.com/news/news-details/2024/gilead-signs-royalty-free-voluntary-licensing-agreements-with-six-generic-manufacturers-to-increase-access-to-lenacapavir-for-hiv-prevention-in-high-incidence-resource-limited-countrieshttps://viivuspricing.com/apretude.htmlhttps://www.drugs.com/price-guide/truvadahttps://www.drugs.com/price-guide/descovyhttps://prep4all.org/https://pubmed.ncbi.nlm.nih.gov/39225016/https://www.kff.org/hivaids/issue-brief/medicaid-and-people-with-hiv/#:~:text=Medicaid%2C%20the%20largest%20public%20health,)%20(see%20Figure%201).https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/hiv/strategic-information/hiv-data-and-statisticshttps://paetc.org/resources/aidsvu-releases-new-prep-data-and-launches-prepvu-org-a-new-prep-equity-platform/https://my.sailthru.com/rm?id=5b455afd52f90838684f0321

Source diversity

9

www.gilead.comviivuspricing.comwww.drugs.comprep4all.orgpubmed.ncbi.nlm.nih.govwww.kff.orgwww.who.intpaetc.orgmy.sailthru.com

Affiliate links

no affiliate links

Read full article